Aneurysmal Subarachnoid Hemorrhage (SAH) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 54 pages | ID: A3DC0CA1AF4EN
VPAResearch

Abstracts

Aneurysmal Subarachnoid Hemorrhage (SAH) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Aneurysmal Subarachnoid Hemorrhage (SAH) disease clinical trials. The research work analyzes the ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Aneurysmal Subarachnoid Hemorrhage (SAH) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trials.

Scope of the Report-

• Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Aneurysmal Subarachnoid Hemorrhage (SAH)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Aneurysmal Subarachnoid Hemorrhage (SAH) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Phase
3.2 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Type
3.3 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials
4.2 Top 10 Countries conducting Aneurysmal Subarachnoid Hemorrhage (SAH) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Sponsor Type
5.2 Aneurysmal Subarachnoid Hemorrhage (SAH) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by year
6.2 Subjects Recruited for Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Phase
6.3 Subjects Recruited for Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Trial Type
6.4 Subjects Recruited for Aneurysmal Subarachnoid Hemorrhage (SAH) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials- Phase
7.2 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials- Phase
7.3 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials- Phase
7.4 Ongoing Aneurysmal Subarachnoid Hemorrhage (SAH) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Country
Figure 2: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Phase of Development, 2018
Figure 3: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Status, 2018
Figure 4: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Type, 2018
Figure 5: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials Split by Region, 2000-2018
Figure 6: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Type of Economy, 2018
Figure 7: Aneurysmal Subarachnoid Hemorrhage (SAH)- Enrolment by Phase, 2018
Figure 8: Aneurysmal Subarachnoid Hemorrhage (SAH)- Enrolment by Trial Type, 2018
Figure 9: Aneurysmal Subarachnoid Hemorrhage (SAH)- Enrolment by Recruitment Status, 2018
Figure 10: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Sponsor Type, 2018
Figure 11: Aneurysmal Subarachnoid Hemorrhage (SAH)- Enrolment by Type of Sponsors
Figure 12: Aneurysmal Subarachnoid Hemorrhage (SAH)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Sponsor Type, 2018
Table 2: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Economy Type, 2018
Table 3: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials by Region, 2018
Table 4: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Aneurysmal Subarachnoid Hemorrhage (SAH)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Aneurysmal Subarachnoid Hemorrhage (SAH)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Aneurysmal Subarachnoid Hemorrhage (SAH)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Aneurysmal Subarachnoid Hemorrhage (SAH)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Aneurysmal Subarachnoid Hemorrhage (SAH)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company